Autoimmune Disease Therapeutics Market Growth 2025-2035

Future Market Insights

Autoimmune Disease Therapeutics Market

Key Insight

Autoimmune disease therapeutics sales will expand through 2035, with dermatology indications at 32.0% within the indication segment and immunomodulators and immunosuppressants at 38.0% of the treatment category in 2025. The market was valued at USD 168.6 billion in 2025 and is forecast to record a 3.0% CAGR between 2025 and 2035.

August 22, 2025

Anurag Sharma

324 Pages

Cite this Report

Autoimmune Disease Therapeutics Market

https://www.futuremarketinsights.com/reports/autoimmune-disease-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

The Vanguard Group
Amgen
Biogen Inc
F. Hoffmann-La Roche Ag
Novartis
L'Oréal
Takeda Pharmaceutical Company Limited
Berkshire Hathaway
UCB S.A

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Autoimmune Disease Therapeutics Market

Key Players

Similar Industry Reports